Share this post:
Case Studies
Investment: New uses for well-known molecule
Provepharm, a private French pharmaceutical company focusing on new areas of discovery, wished to announce its €120M investment to enable it to make major steps forward in its Horizon 2025 strategy.
To download documents, you can right-click on the links above and chose « Save link as… »